Ontology highlight
ABSTRACT: Background
Residual disease of glioblastoma (GBM) causes recurrence. However, targeting residual cells has failed, due to their inaccessibility and our lack of understanding of their survival mechanisms to radiation therapy. Here we deciphered a residual cell-specific survival mechanism essential for GBM relapse.Methods
Therapy resistant residual (RR) cells were captured from primary patient samples and cell line models mimicking clinical scenario of radiation resistance. Molecular signaling of resistance in RR cells was identified using RNA sequencing, genetic and pharmacological perturbations, overexpression systems, and molecular and biochemical assays. Findings were validated in patient samples and an orthotopic mouse model.Results
RR cells form more aggressive
SUBMITTER: Kaur E
PROVIDER: S-EPMC7746947 | biostudies-literature | 2020 Dec
REPOSITORIES: biostudies-literature